Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

In Vivo Volume Dynamics of Dendritic Spines in the Neocortex of Wild-Type and Fmr1 KO Mice.

Ishii K, Nagaoka A, Kishida Y, Okazaki H, Yagishita S, Ucar H, Takahashi N, Saito N, Kasai H.

eNeuro. 2018 Nov 8;5(5). pii: ENEURO.0282-18.2018. doi: 10.1523/ENEURO.0282-18.2018. eCollection 2018 Sep-Oct.

2.

Radical Resection of Craniopharyngioma: Discussions Based on Long-term Clinical Course and Histopathology of the Dissection Plane.

Okada T, Fujitsu K, Ichikawa T, Miyahara K, Tanino S, Uriu Y, Tanaka Y, Niino H, Yagishita S.

Asian J Neurosurg. 2018 Jul-Sep;13(3):640-646. doi: 10.4103/ajns.AJNS_258_16.

3.

A Case of a Pregnant Woman Diagnosed as Having ALK-rearranged Lung Adenocarcinoma.

Komura M, Yagishita S, Nakamura K, Arano N, Takeshige T, Muraki K, Nagashima O, Izumi H, Tomita S, Sasaki S, Takahashi K.

In Vivo. 2018 Sep-Oct;32(5):1205-1209. doi: 10.21873/invivo.11365.

4.

Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.

Kanemaru R, Takahashi F, Kato M, Mitsuishi Y, Tajima K, Ihara H, Hidayat M, Wirawan A, Koinuma Y, Hayakawa D, Yagishita S, Ko R, Sato T, Harada N, Kodama Y, Nurwidya F, Sasaki S, Niwa SI, Takahashi K.

Lung. 2018 Oct;196(5):531-541. doi: 10.1007/s00408-018-0134-6. Epub 2018 Jun 20.

PMID:
29926178
5.

Intracranial epidermoid cyst with proliferative folliculosebaceous epithelium: Report of a rare case and discussion on pathogenesis.

Okada T, Fujitsu K, Ichikawa T, Miyahara K, Tanino S, Uriu Y, Hataoka S, Tanaka Y, Suzuki K, Niino H, Yagishita S, Kato I.

Neuropathology. 2018 Oct;38(5):510-515. doi: 10.1111/neup.12481. Epub 2018 Jun 6.

PMID:
29876981
6.

Correction to: Protective and therapeutic role of 2-carbacyclic phosphatidic acid in demyelinating disease.

Yamamoto S, Yamashina K, Ishikawa M, Gotoh M, Yagishita S, Iwasa K, Maruyama K, Murakami-Murofushi K, Yoshikawa K.

J Neuroinflammation. 2018 Mar 5;15(1):67. doi: 10.1186/s12974-018-1104-x.

7.

Calcineurin knockout mice show a selective loss of small spines.

Okazaki H, Hayashi-Takagi A, Nagaoka A, Negishi M, Ucar H, Yagishita S, Ishii K, Toyoizumi T, Fox K, Kasai H.

Neurosci Lett. 2018 Apr 3;671:99-102. doi: 10.1016/j.neulet.2018.02.006. Epub 2018 Feb 7.

8.

LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer.

Jotatsu T, Yagishita S, Tajima K, Takahashi F, Mogushi K, Hidayat M, Wirawan A, Ko R, Kanemaru R, Shimada N, Mitani K, Saito T, Takamochi K, Suzuki K, Kohsaka S, Kojima S, Mukae H, Yatera K, Takahashi K.

Biochem Biophys Rep. 2016 Dec 1;9:86-94. doi: 10.1016/j.bbrep.2016.11.015. eCollection 2017 Mar.

9.

Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.

Yamamoto S, Yamashina K, Ishikawa M, Gotoh M, Yagishita S, Iwasa K, Maruyama K, Murakami-Murofushi K, Yoshikawa K.

J Neuroinflammation. 2017 Jul 21;14(1):142. doi: 10.1186/s12974-017-0923-5. Erratum in: J Neuroinflammation. 2018 Mar 5;15(1):67.

10.

Intermittent hypoxia produces Alzheimer disease?

Yagishita S, Hirasawa A.

Oncotarget. 2017 Jun 27;8(26):41786-41787. doi: 10.18632/oncotarget.18214. No abstract available.

11.

Engineering Pak1 Allosteric Switches.

Dagliyan O, Karginov AV, Yagishita S, Gale ME, Wang H, DerMardirossian C, Wells CM, Dokholyan NV, Kasai H, Hahn KM.

ACS Synth Biol. 2017 Jul 21;6(7):1257-1262. doi: 10.1021/acssynbio.6b00359. Epub 2017 Apr 6.

12.

A novel form of necrosis, TRIAD, occurs in human Huntington's disease.

Yamanishi E, Hasegawa K, Fujita K, Ichinose S, Yagishita S, Murata M, Tagawa K, Akashi T, Eishi Y, Okazawa H.

Acta Neuropathol Commun. 2017 Mar 8;5(1):19. doi: 10.1186/s40478-017-0420-1.

13.

Structural transformations of layered structures constructed from Cu(ii)-chloranilate monomer compounds.

Yagishita S, Himegi A, Kanazashi K, Ohishi T, Ishikawa R, Hamaguchi T, Kawata S.

Dalton Trans. 2017 Feb 28;46(9):2966-2973. doi: 10.1039/c6dt04867f.

PMID:
28198485
14.

Excitotoxicity-induced prostaglandin D2 production induces sustained microglial activation and delayed neuronal death.

Iwasa K, Yamamoto S, Yagishita S, Maruyama K, Yoshikawa K.

J Lipid Res. 2017 Apr;58(4):649-655. doi: 10.1194/jlr.M070532. Epub 2017 Feb 7.

15.

Treatment of intermittent hypoxia increases phosphorylated tau in the hippocampus via biological processes common to aging.

Yagishita S, Suzuki S, Yoshikawa K, Iida K, Hirata A, Suzuki M, Takashima A, Maruyama K, Hirasawa A, Awaji T.

Mol Brain. 2017 Jan 5;10(1):2. doi: 10.1186/s13041-016-0282-7.

16.

Perturbed Calcineurin-NFAT Signaling Is Associated with the Development of Alzheimer's Disease.

Asai M, Kinjo A, Kimura S, Mori R, Kawakubo T, Shirotani K, Yagishita S, Maruyama K, Iwata N.

Biol Pharm Bull. 2016;39(10):1646-1652.

17.

Specific combinations of presenilins and Aph1s affect the substrate specificity and activity of γ-secretase.

Yonemura Y, Futai E, Yagishita S, Kaether C, Ishiura S.

Biochem Biophys Res Commun. 2016 Sep 30;478(4):1751-7. doi: 10.1016/j.bbrc.2016.09.018. Epub 2016 Sep 5.

18.

Proton conduction via lattice water molecules in oxalato-bridged lanthanide porous coordination polymers.

Ishikawa R, Ueno S, Yagishita S, Kumagai H, Breedlove BK, Kawata S.

Dalton Trans. 2016 Oct 21;45(39):15399-15405. Epub 2016 Sep 6.

PMID:
27602984
19.

State-dependent diffusion of actin-depolymerizing factor/cofilin underlies the enlargement and shrinkage of dendritic spines.

Noguchi J, Hayama T, Watanabe S, Ucar H, Yagishita S, Takahashi N, Kasai H.

Sci Rep. 2016 Sep 6;6:32897. doi: 10.1038/srep32897.

20.

Oriented collagen tubes combined with basic fibroblast growth factor promote peripheral nerve regeneration in a 15 mm sciatic nerve defect rat model.

Fujimaki H, Uchida K, Inoue G, Miyagi M, Nemoto N, Saku T, Isobe Y, Inage K, Matsushita O, Yagishita S, Sato J, Takano S, Sakuma Y, Ohtori S, Takahashi K, Takaso M.

J Biomed Mater Res A. 2017 Jan;105(1):8-14. doi: 10.1002/jbm.a.35866. Epub 2016 Aug 21.

PMID:
27529414
21.

Abnormal intrinsic dynamics of dendritic spines in a fragile X syndrome mouse model in vivo.

Nagaoka A, Takehara H, Hayashi-Takagi A, Noguchi J, Ishii K, Shirai F, Yagishita S, Akagi T, Ichiki T, Kasai H.

Sci Rep. 2016 May 25;6:26651. doi: 10.1038/srep26651.

22.

Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.

Kobayashi I, Takahashi F, Nurwidya F, Nara T, Hashimoto M, Murakami A, Yagishita S, Tajima K, Hidayat M, Shimada N, Suina K, Yoshioka Y, Sasaki S, Moriyama M, Moriyama H, Takahashi K.

Biochem Biophys Res Commun. 2016 Apr 22;473(1):125-132. doi: 10.1016/j.bbrc.2016.03.064. Epub 2016 Mar 17.

PMID:
26996130
23.

Unicystic Ameloblastomatoid Cystic Craniopharyngioma: Pathological Discussion and Clinical Significance of Cyst Formation in Adamantinomatous Craniopharyngioma.

Okada T, Fujitsu K, Ichikawa T, Miyahara K, Tanino S, Niino H, Yagishita S.

Pediatr Neurosurg. 2016;51(3):158-63. doi: 10.1159/000442992. Epub 2016 Jan 22.

PMID:
26795029
24.

Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells.

Sawada T, Watanabe M, Fujimura Y, Yagishita S, Shimoyama T, Maeda Y, Kanda S, Yunokawa M, Tamura K, Tamura T, Minami H, Koh Y, Koizumi F.

Cancer Sci. 2016 Mar;107(3):307-14. doi: 10.1111/cas.12868. Epub 2016 Feb 23.

25.

Glycogen Synthase Kinase 3β-mediated Phosphorylation in the Most C-terminal Region of Protein Interacting with C Kinase 1 (PICK1) Regulates the Binding of PICK1 to Glutamate Receptor Subunit GluA2.

Yagishita S, Murayama M, Ebihara T, Maruyama K, Takashima A.

J Biol Chem. 2015 Dec 4;290(49):29438-48. doi: 10.1074/jbc.M114.619668. Epub 2015 Oct 15.

26.

Two-photon fluorescence lifetime imaging of primed SNARE complexes in presynaptic terminals and β cells.

Takahashi N, Sawada W, Noguchi J, Watanabe S, Ucar H, Hayashi-Takagi A, Yagishita S, Ohno M, Tokumaru H, Kasai H.

Nat Commun. 2015 Oct 6;6:8531. doi: 10.1038/ncomms9531.

27.

A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC).

Mizugaki H, Yamamoto N, Nokihara H, Fujiwara Y, Horinouchi H, Kanda S, Kitazono S, Yagishita S, Xiong H, Qian J, Hashiba H, Shepherd SP, Giranda V, Tamura T.

Cancer Chemother Pharmacol. 2015 Nov;76(5):1063-72. doi: 10.1007/s00280-015-2876-7. Epub 2015 Oct 3.

28.

Labelling and optical erasure of synaptic memory traces in the motor cortex.

Hayashi-Takagi A, Yagishita S, Nakamura M, Shirai F, Wu YI, Loshbaugh AL, Kuhlman B, Hahn KM, Kasai H.

Nature. 2015 Sep 17;525(7569):333-8. doi: 10.1038/nature15257. Epub 2015 Sep 9.

29.

Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.

Shukuya T, Ko R, Mori K, Kato M, Yagishita S, Kanemaru R, Honma Y, Shibayama R, Koyama R, Shimada N, Takahashi K.

Cancer Chemother Pharmacol. 2015 Oct;76(4):771-6. doi: 10.1007/s00280-015-2843-3. Epub 2015 Aug 11.

PMID:
26259641
30.

Hydrothermal Synthesis of Yttria-Stabilized Zirconia Nanocrystals with Controlled Yttria Content.

Sato K, Horiguchi K, Nishikawa T, Yagishita S, Kuruma K, Murakami T, Abe H.

Inorg Chem. 2015 Aug 17;54(16):7976-84. doi: 10.1021/acs.inorgchem.5b01112. Epub 2015 Jul 31.

PMID:
26230644
31.

Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer.

Yagishita S, Horinouchi H, Sunami KS, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Sumi M, Shiraishi K, Kohno T, Furuta K, Tsuta K, Tamura T, Ohe Y.

Cancer Sci. 2015 Oct;106(10):1402-7. doi: 10.1111/cas.12740. Epub 2015 Aug 18.

32.

Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains.

Satoh J, Kino Y, Motohashi N, Ishida T, Yagishita S, Jinnai K, Arai N, Nakamagoe K, Tamaoka A, Saito Y, Arima K.

Neuropathology. 2015 Dec;35(6):529-37. doi: 10.1111/neup.12222. Epub 2015 Jun 18.

PMID:
26087043
33.

Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer.

Horinouchi H, Yamamoto N, Fujiwara Y, Sekine I, Nokihara H, Kubota K, Kanda S, Yagishita S, Wakui H, Kitazono S, Mizugaki H, Tokudome T, Tamura T.

Invest New Drugs. 2015 Aug;33(4):881-9. doi: 10.1007/s10637-015-0243-5. Epub 2015 May 1.

34.

Chemotherapy-Regulated microRNA-125-HER2 Pathway as a Novel Therapeutic Target for Trastuzumab-Mediated Cellular Cytotoxicity in Small Cell Lung Cancer.

Yagishita S, Fujita Y, Kitazono S, Ko R, Nakadate Y, Sawada T, Kitamura Y, Shimoyama T, Maeda Y, Takahashi F, Takahashi K, Tamura T, Koizumi F.

Mol Cancer Ther. 2015 Jun;14(6):1414-23. doi: 10.1158/1535-7163.MCT-14-0625. Epub 2015 Apr 1.

35.

The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer.

Fujita Y, Yagishita S, Hagiwara K, Yoshioka Y, Kosaka N, Takeshita F, Fujiwara T, Tsuta K, Nokihara H, Tamura T, Asamura H, Kawaishi M, Kuwano K, Ochiya T.

Mol Ther. 2015 Apr;23(4):717-27. doi: 10.1038/mt.2015.10. Epub 2015 Jan 19.

36.

Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer.

Fujita Y, Yagishita S, Takeshita F, Yamamoto Y, Kuwano K, Ochiya T.

Oncotarget. 2015 Feb 20;6(5):3335-45.

37.

Pathological characteristics of cyst formation following gamma knife surgery for arteriovenous malformation.

Shuto T, Yagishita S, Matsunaga S.

Acta Neurochir (Wien). 2015 Feb;157(2):293-8. doi: 10.1007/s00701-014-2298-z. Epub 2014 Dec 13.

PMID:
25503297
38.

Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.

Nurwidya F, Takahashi F, Kobayashi I, Murakami A, Kato M, Minakata K, Nara T, Hashimoto M, Yagishita S, Baskoro H, Hidayat M, Shimada N, Takahashi K.

Biochem Biophys Res Commun. 2014 Dec 12;455(3-4):332-8. doi: 10.1016/j.bbrc.2014.11.014. Epub 2014 Nov 15.

PMID:
25446090
39.

Epidermal growth factor receptor mutation is associated with longer local control after definitive chemoradiotherapy in patients with stage III nonsquamous non-small-cell lung cancer.

Yagishita S, Horinouchi H, Katsui Taniyama T, Nakamichi S, Kitazono S, Mizugaki H, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Sumi M, Shiraishi K, Kohno T, Furuta K, Tsuta K, Tamura T.

Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):140-8. doi: 10.1016/j.ijrobp.2014.08.344. Epub 2014 Oct 13.

PMID:
25442336
40.

Clinical pharmacology of EGFR/Met inhibitors in non-small cell lung cancer.

Yagishita S, Hamada A.

Curr Drug Targets. 2014;15(14):1263-72. Review.

PMID:
25382203
41.

A critical time window for dopamine actions on the structural plasticity of dendritic spines.

Yagishita S, Hayashi-Takagi A, Ellis-Davies GC, Urakubo H, Ishii S, Kasai H.

Science. 2014 Sep 26;345(6204):1616-20. doi: 10.1126/science.1255514.

42.

Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.

Iwasa K, Yamamoto S, Takahashi M, Suzuki S, Yagishita S, Awaji T, Maruyama K, Yoshikawa K.

Prostaglandins Leukot Essent Fatty Acids. 2014 Nov;91(5):175-82. doi: 10.1016/j.plefa.2014.08.004. Epub 2014 Sep 6.

PMID:
25224839
43.

Adjuvant chemotherapy in patients with completely resected small cell lung cancer: a retrospective analysis of 26 consecutive cases.

Mizugaki H, Fujiwara Y, Yamamoto N, Yagishita S, Kitazono S, Tanaka A, Horinouchi H, Kanda S, Nokihara H, Tsuta K, Asamura H, Tamura T.

Jpn J Clin Oncol. 2014 Sep;44(9):835-40. doi: 10.1093/jjco/hyu092. Epub 2014 Aug 5.

PMID:
25097183
44.

Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice.

Yamamoto S, Gotoh M, Kawamura Y, Yamashina K, Yagishita S, Awaji T, Tanaka M, Maruyama K, Murakami-Murofushi K, Yoshikawa K.

Eur J Pharmacol. 2014 Oct 15;741:17-24. doi: 10.1016/j.ejphar.2014.07.040. Epub 2014 Jul 30.

PMID:
25084219
45.

Obstructive hydrocephalus and leptomeningeal dissemination with an unknown primary lesion in a 67-year-old man.

Miyaji Y, Yagishita S, Zhang N, Watanabe D, Miyasaki H, Mabuchi I, Taira S, Tanaka F.

Neuropathology. 2014 Dec;34(6):596-601. doi: 10.1111/neup.12136. Epub 2014 Jul 2. No abstract available.

PMID:
24985223
46.

LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains.

Satoh J, Motohashi N, Kino Y, Ishida T, Yagishita S, Jinnai K, Arai N, Nakamagoe K, Tamaoka A, Saito Y, Arima K.

Orphanet J Rare Dis. 2014 May 1;9:68. doi: 10.1186/1750-1172-9-68.

47.
48.

A strongly CD34-positive meningioma that was difficult to distinguish from a solitary fibrous tumor.

Okada T, Fujitsu K, Ichikawa T, Mukaihara S, Miyahara K, Tanino S, Uriu Y, Sakamoto T, Hataoka S, Kubota J, Suzuki K, Niino H, Yagishita S.

Ultrastruct Pathol. 2014 Aug;38(4):290-4. doi: 10.3109/01913123.2014.888115. Epub 2014 Feb 28.

PMID:
24579869
49.

Late onset GM2 gangliosidosis presenting with motor neuron disease: an autopsy case.

Yokoyama T, Nakamura S, Horiuchi E, Ishiyama M, Kawashima R, Nakamura K, Hasegawa K, Yagishita S.

Neuropathology. 2014 Jun;34(3):304-8. doi: 10.1111/neup.12088. Epub 2013 Dec 20.

PMID:
24354582
50.

Secondary osteosarcoma developing 10 years after chemoradiotherapy for non-small-cell lung cancer.

Yagishita S, Horinouchi H, Yorozu T, Kitazono S, Mizugaki H, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Mori T, Tsuta K, Sumi M, Tamura T.

Jpn J Clin Oncol. 2014 Feb;44(2):191-4. doi: 10.1093/jjco/hyt192. Epub 2013 Dec 13.

PMID:
24338556

Supplemental Content

Loading ...
Support Center